Kubota Yoshifumi, Hase Ryota, Kurita Takashi, Mito Haruki, Yano Yudai
Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan.
Department of Infectious Diseases, Kameda Medical Center, Kamogawa, Chiba, Japan.
Glob Health Med. 2022 Jun 30;4(3):197-200. doi: 10.35772/ghm.2021.01126.
International medical evacuation, which is an option to receive better medical care for travelers with emergencies staying in low- and middle-income countries, has been more challenging during the coronavirus disease 2019 (COVID-19) pandemic. We herein discuss our experience with four Japanese patients with COVID-19 who required medical evacuation from Asian countries during the pandemic. Of these, none of the patients had received a COVID-19 vaccine; three patients needed oxygen therapy on admission to our hospital; and one patient died due to respiratory failure on day 50 after hospitalization. It was observed that multidrug-resistant organisms were colonized in two patients after obtaining culture results based on active surveillance. Strict infection control measures against multidrug-resistant organisms should be implemented during the care of patients with COVID-19 who require medical evacuation from high-risk countries. Further, it is important to communicate timely updates regarding the patient's condition with travel assistance agencies as the patient's condition may rapidly change during the course of arranging the evacuation.
国际医疗后送是为身处低收入和中等收入国家且遭遇紧急情况的旅行者提供更好医疗服务的一种选择,但在2019冠状病毒病(COVID-19)大流行期间,这种后送变得更具挑战性。在此,我们讨论在大流行期间对4名需要从亚洲国家进行医疗后送的日本COVID-19患者的救治经验。其中,没有一名患者接种过COVID-19疫苗;3名患者入院时需要吸氧治疗;1名患者在住院50天后因呼吸衰竭死亡。在根据主动监测获得培养结果后,观察到两名患者存在多重耐药菌定植。在对需要从高风险国家进行医疗后送的COVID-19患者进行护理时,应针对多重耐药菌实施严格的感染控制措施。此外,由于在安排后送的过程中患者病情可能迅速变化,及时与旅行协助机构沟通患者病情的最新情况很重要。